GABA plays a key role in both embryonic and neonatal brain development. For example, during early neonatal nervous system maturation, synaptic transmission, mediated by GABA A receptors (GABA A Rs), undergoes a temporally specific form of synaptic plasticity, to accommodate the changing requirements of maturing neural networks. Specifically, the duration of miniature inhibitory postsynaptic currents (mIPSCs), resulting from vesicular GABA activating synaptic GABA A Rs, is reduced, permitting neurons to appropriately influence the window for postsynaptic excitation. Conventionally, programmed expression changes to the subtype of synaptic GABA A R are primarily implicated in this plasticity. However, it is now evident that in developing thalamic and cortical principal-and inter-neurons an endogenous neurosteroid tone e.g. allopregnanolone, enhances synaptic GABA A R function. Furthermore, a cessation of steroidogenesis, due to a lack of
Introduction
From an early embryonic age, GABA-ergic signalling plays a fundamental role in neuronal development, influencing neuronal proliferation, migration and differentiation and is important in the establishment of neuronal networks [1] [2] [3] [4] .
These effects of GABA are mediated by ionotropic GABA A receptors (GABA A Rs), or by G-protein coupled GABA B receptors. Certain steroids are potent, endogenous, positive allosteric modulators (PAMs) of the GABA A R diol-20-one; 5α-THDOC) act as potent and selective positive allosteric modulators (PAMs) of the major inhibitory receptor in the mammalian brain, the GABA A R 5,10-14 ( Figure 1 ).
GABA A Rs belong to the transmitter-gated ion channel superfamily and are composed of five subunits arranged around a central pore to form an anionconducting ion channel 15, 16 . Low nM aqueous concentrations of these neuroactive steroids enhance the actions of GABA by promoting the anionconducting state of the associated channel 11, 14, 17, 18 . Their activity at such low concentrations suggests the presence of a high affinity steroid binding site on the GABA A R. However, these steroids are highly lipophilic, resulting in relatively high membrane concentrations in close proximity to the proposed transmembrane binding site on the GABA A R 19, 20 . Therefore, the steroid may have a relatively low affinity for the receptor, but be optimally concentrated, locally in the membrane, leading to an increased probability that the steroid will occupy the receptor binding site 19, 20 . The GABA A R is the target for clinically important drugs, e.g. benzodiazepines and certain general anaesthetics, which enhance the GABA A R function 5 . In common with such drugs, administration of neuroactive steroids produce anxiolytic, analgesic, anticonvulsant and sedative effects, with higher doses capable of inducing a general anaesthetic state 5, 8 .
Initially, endocrine glands such as the adrenals and ovaries were considered the exclusive source of steroid, necessitating it to cross the blood brain barrier to influence neural activity. Subsequently, compelling evidence emerged for de novo brain synthesis i.e. neurosteroids 21 . Hence, these endogenous GABA A Rmodulators may potentially act in an endocrine, paracrine, or autocrine manner, to influence neuronal signalling in various physiological and pathological situations. Indeed, neurosteroid levels are dynamically changed in a variety of physiological (e.g. development, puberty, pregnancy, stress, ovarian cycle) and pathophysiological (e.g. major depression, postpartum depression, premenstrual tension, panic attacks and schizophrenia) scenarios 5 
.
In the brain and spinal cord the GABA A R-active steroids such as allopregnanolone and 5α-THDOC may a) originate from peripheral sources e.g. placenta, ovaries and adrenals necessitating them crossing the blood brain barrier 22 ; b) be derived from their peripheral hormonal precursors, progesterone and deoxycorticosterone, or c) be synthesised de novo from
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cholesterol via a series of multi-enzymatic steps 23 . Diverse approaches including in situ hybridization, immunohistochemistry, gas chromatography mass spectrometry, electrophysiology and behaviour, purport that neurosteroids, synthesised by neurons and/or glia may achieve levels sufficient to influence in a paracrine and/or autocrine fashion GABA A R signalling from the onset of embryonic GABAergic transmission into maturity 5, [24] [25] [26] [27] [28] [29] . The suite of enzymes that synthesise neurosteroids exhibit regional and cellular-selective expression patterns, which change within discrete temporal windows and are susceptible to external challenges, e.g. stress 23, [30] [31] [32] [33] . In the CNS the production of GABA A R-active neurosteroids from cholesterol ( Figure 1 ) first requires the translocation of the steroid across the mitochondrial membrane by translocator protein 18 kDa (TSPO) 34, 35 . Cholesterol is then metabolised to pregnenolone by the mitochondrial P450 side-chain cleavage enzyme CYP11A1, this metabolite is then exported across the mitochondrial membrane, where it may be converted to GABA A R-active neurosteroids such as allopregnanolone following three sequential enzyme reactions catalysed by 3β-hydroxysteroid dehydrogenase (3β-HSD) to form progesterone, 5α-reductase (5α-R) to produce 5α-dihydroprogesterone (5α-DHP) and 3α-hydroxysteroid dehydrogenase (3α-HSD) to form allopregnanolone (Figure 1 Note both in the CNS and the periphery the enzymes 5α-R and 3α-HSD may sequentially participate in the conversion of deoxycorticosterone derived primarily from the adrenals into the GABA A R-active 5α-THDOC 22 . We have recently reviewed the expression of 5α-R and 3α-HSD in mammalian brain 24 , (see also [30] [31] [32] [33] ). As GABA plays a crucial role in neurodevelopment, during this critical time of neonatal development it is conceivable that the changing levels of neurosteroids, from CNS-located paracrine, or autocrine sources, may influence the establishment of mature neuronal circuits and communication. Additionally, neonatal endocrine glands such as the adrenals may provide the brain and spinal cord with either the GABA A R-active steroids per se, or their precursors 22, 36, 37 .
GABA A Rs.
The GABA A R subunits are drawn from a repertoire of 19 gene products belonging to distinct families including: α1-6; β1-3; γ1-3, δ, ε, θ, π and ρ1-3 15, 16 . In the adult mammalian brain this diversity underpins the expression of 20-30 GABA A R subtypes, that are uniquely distributed and consequently influence particular behaviours [38] [39] [40] . Although neuroactive steroids are highly selective for GABA A . The neuronal location of the receptor influences the GABA inhibitory signalling repertoire of the neuron. Receptors clustered in the post-synaptic domain primarily serve to mediate a fast, phasic form of inhibition in response to relatively high local concentrations of neurotransmitter, which occur in the synapse following the vesicular release of GABA 41 . By contrast, receptors in peri-synaptic and extra-synaptic locations are activated by ambient concentrations of GABA to mediate a sustained, or tonic form of neuronal inhibition 41 . However, in some neurons during physiological bursts of high frequency presynaptic stimulation the spill-over of GABA from the synapse is sufficient to additionally engage these extrasynaptic receptors to produce a greatly prolonged form of slow phasic inhibition [45] [46] [47] . The majority of GABA A Rs contain two α and two β subunits together with a single copy of the γ2 subunit. Synaptic receptors often contain the γ2 subunit, although receptors incorporating this subunit may be located out with the synapse. Receptors incorporating the δ subunit, in place of the γ2 subunit are expressed extra-or peri-synaptically 41, 42, 48, 49 .
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GABA A R subunit expression and function during embryonic and post-natal development.
In the adult brain, activation of GABA A Rs usually causes an inhibitory effect on neuronal excitability, conferred both by a net inward directed flow of Cl -ions and the shunting action of GABA
50
. However, early in development (embryonic and first postnatal week), GABA A R activation results in neuronal depolarization, due to a relatively high intracellular Cl -concentration, resulting from limited expression of KCC2, the principal neuronal transporter for Cl -ion extrusion 51 . Although the validity of this developmental ionic perturbation has been challenged, under certain experimental conditions [52] [53] [54] , the depolarizing nature of these early GABA-ergic signals may be sufficient to activate voltagedependent calcium, or sodium channels and appear pivotal to the neurotrophic actions of the neurotransmitter [55] [56] [57] . Furthermore, during embryogenesis, such depolarizations are primarily mediated by activation of extra-synaptic GABA A Rs, which are expressed prior to and indeed facilitate the establishment of functionally relevant synaptic connections after birth 2, 3 . During early development the subunit composition of GABA A Rs is highly plastic, consequently impacting upon the physiological and pharmacological properties of the receptors and influencing their subcellular localization 15, 42 . Preceding the generation, migration, and differentiation of most telencephalic and mesencephalic neurons 58, 59 , the first detection of GABA A R subunits (including α1-5, β1-3 and γ1-3), coincides with the appearance of GABA-positive neurons at approximately E13-14 in the marginal zone, sub-plate, and sub-ventricular zone 60, 61 . For rodent brain, the end of the first postnatal week generally signals a change to a hyperpolarizing GABA A R response 1 . Depending on the specific brain region, postnatal weeks two to three mark the establishment of a nearmature synaptic network, which reaches an adult stage by about two months of age following sexual maturation. From approximately the end of the first postnatal week synaptic GABA A R signals, resulting from the vesicular release of GABA, begin to play an important role in shaping the development of neuronal circuits 62 .
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As the postnatal brain develops there is an increased requirement for temporal precision within neuronal networks and accordingly, in many neurons the duration of phasic events e.g. miniature inhibitory postsynaptic currents (mIPSCs) mediated by the activation of synaptic GABA A Rs by GABA released from a single vesicle, is progressively reduced 42, [63] [64] [65] [66] [67] [68] [69] . This critical development of GABA-ergic signalling is generally considered to result from a genetically programmed change of the subtype of synaptic GABA A R. In this regard the α-subunit isoform exerts a profound role on the duration of GABA A R-mediated phasic events. For example, electrophysiological studies with expressed recombinant GABA A Rs demonstrates the duration of GABA-evoked currents mediated by receptors incorporating either α2-, or α3-subunits are prolonged compared to equivalent receptors containing the α1 subunit 70 , although the β and γ subunit isoforms may also influence the mIPSC decay 71, 72 . Of physiological relevance, in different neurons (e.g. principal glutamatergic neurons and GABAergic interneurons) expression of different synaptic GABA A R isoforms results in kinetically distinct synaptic events, underpinning the integration of neuronal signals and network activity and allowing the establishment of behaviourally relevant neuronal rhythms 73, 74 . Many neurons express multiple GABA A R isoforms, complicating evaluation of their role in neonatal development. To study this in detail we have used the ventrobasal (VB) neurons of the mouse thalamus. These neurons provide an ideal model as they exhibit a clear developmental transition from synaptic α2-GABA A Rs from postnatal weeks 1-2, to α1-GABA A Rs in weeks 2-3 75 ( Figure   2 ).They are innervated by a band of GABA-ergic neurons, the nucleus reticularis (nRT neurons), which release GABA onto the VB neurons. Our studies, described below, reveal an important role for GABA-modulatory neurosteroids in determining the duration of mIPSCs during neonatal development.
During postnatal development of thalamic VB neurons neurosteroids, in concert with changes to GABA A R isoforms, influence phasic and tonic inhibition.
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We reported that the duration of thalamocortical VB neuron mIPSCs is greatly reduced over a critical, short period of 1-2 days between postnatal days (P) 9-11 75 . Synaptic receptors incorporating the α1-subunit are associated with brief mIPSCs 63, 75 . Implicating changes to synaptic GABA A Rs, our immunohistochemical and electrophysiological studies with an α1 "knock-out" mouse and benzodiazepine-insensitive knock-in (α1H101R; α2H101R) mice revealed P20 neurons to exclusively express synaptic α1βγ2 GABA A Rs, whilst younger mice expressed the α2βγ2 isoform 75 ( Figure 2 ). However, the major change to the mIPSC duration, occurred prior (P9-11) to the synaptic α2-to α1-GABA A R transition 75 and were replicated in an α1 -/-mouse 75 . Clearly, this initial P9-11 synaptic plasticity does not result from expression of α1-GABA A Rs 75 . During postnatal development the levels of GABA A R-modulatory neurosteroids change 76 . Do neurosteroids influence neural inhibition during postnatal development (P7-24)? Preventing neurosteroid synthesis in P7 thalamus with the 5α-reductase inhibitor finasteride significantly reduced mIPSC duration 77 . Intracellular delivery of the neurosteroid scavenger γ-cyclodextrin [γ-CD] [78] [79] [80] , produced the same effect 77 , but by P10 was inert (Figure 2,3) . Exogenous 5α3α was equieffective in prolonging mIPSCs of P7 and P20-24 neurons. Therefore, the developmental change in the mIPSCs is not a consequence of synaptic GABA A Rs steroid-insensitivity, but results from a loss of the neurosteroid 77 .
Note that the duration of both control and γ-CD-treated P20-24 mIPSCs are further reduced c.f. P10 mIPSCs, a change which corresponds temporally with the exchange of synaptic α2-GABA A Rs by α1-GABA A Rs 77 ( Figure 2 ). Hence, prior to P10 the mIPSC duration is reduced, caused by decreased neurosteroid levels, with subsequent further kinetic refinement resulting from a change in the synaptic GABA A R subtype ( Figure 2) . A recent study suggested that hippocampal expression of the GABA A R α2-subunit was increased by GABA A Ractive neurosteroids 81 . Therefore, it is conceivable that a waning neurosteroid tone heralds the programmed subsequent loss of thalamic synaptic α2-GABA A Rs post P10.
The source of the neurosteroid influencing P7-8 neurons is not known. Studies using an antibody against the neurosteroid suggest that the VB neurons contain 5α3α 82 . Inclusion in the recording pipette of the membraneimpermeant γ-CD (0.5 mM), caused a time-dependent (> 6 min) decrease in the mIPSC duration of P7 VB neurons, mirroring the effect of pre-incubated γ-CD and of finasteride pre-treatment 77 . These studies demonstrate that VB neurons contain GABA A R-active neurosteroids, but do not elucidate whether their source is autocrine, paracrine, or indeed a consequence of prior endocrine release 5 . We suggest that by P10 the local neurosteroid levels are insufficient to influence GABA-ergic neurotransmission. Can the more mature thalamus synthesise neuroactive steroids? Incubation of thalamic slices with 5α-DHP, the immediate precursor of allopregnanolone (Figure 1 ), caused a substantial prolongation of mIPSCs of both P20-24 and P7 neurons 77 , which was prevented by indomethacin, an inhibitor of 3α-hydroxysteroid dehydrogenase (3α-HSD), the enzyme that converts 5α-DHP to the GABA A R-active allopregnanolone ( Figure 1 ). Although indomethacin is not a selective inhibitor of the 3α-HSD enzyme, this effect of 5α-DHP to prolong the mIPSCs was reversed by γ-CD treatment.
Collectively, these results demonstrate that the more mature (P20-24) thalamic slice retains the ability to synthesise GABA A R-active neurosteroids and that the change in mIPSC duration at P9-10 results from a loss of steroid substrate, or a co-factor e.g. NADPH, see 83 . P20-24 VB neurons express synaptic α1β2γ2 and extrasynaptic α4β2δ GABA A Rs that mediate phasic and tonic inhibition respectively 75, 84 . Although the P20-24 mIPSCs were insensitive to γ-CD treatment, suggesting that local neurosteroid levels are insufficient to impact upon synaptic GABA A Rs, neurosteroids are particularly efficacious upon recombinant receptors incorporating the δ-subunit 85,86 . However, the magnitude of the thalamic tonic current mediated by α4β2δ-GABA A Rs was not influenced by γ-CD pre-incubation, suggesting that in P20-24 VB neurons the neurosteroid levels are not sufficient to influence either synaptic, or extrasynaptic GABA A Rs 77 . Nevertheless, incubation with the precursor 5α-DHP, resulted in a large increase of the tonic current, illustrating that neurosteroid production can be reinitiated sufficiently to influence both phasic and tonic inhibition 77 .
The mIPSC frequency of P10-24 VB neurons was much greater than that of P7 neurons. Unexpectedly, incubation with finasteride greatly increased the mIPSC frequency of P7, but not of P10 VB neurons. Furthermore, 5α-DHP greatly reduced the mIPSC frequency of P20-24 VB neurons, an effect probably mediated by allopregnanolone, as indomethacin prevented this suppression of vesicular release by 5α-DHP. Hence, vesicular GABA release from P7 nRT neurons is governed by a neurosteroid tone which, as it wanes, results in an increased mIPSC frequency for P10-24 neurons 77 . These effects of the steroid metabolite appear unlikely to be mediated by presynaptic nRT GABA A Rs as other enhancers of GABA A R function (pentobarbital, etomidate and zolpidem) had no effect on quantal GABA release 77 and therefore the steroid may act via alternative targets e.g voltage-gated T-type calcium channels
87
.
A neurosteroid influence on GABA-ergic transmission of the developing mouse cortex.
Given the sudden loss of neurosteroid influence for P10 VB neurons we investigated whether GABA-ergic transmission in another brain region was similarly influenced and if so determine whether the temporal neurosteroid profile was similar to thalamus. These thalamic relay VB neurons send projections to cortical layer 4 (L4) neurons during P4-8 and subsequently (P10-14) L4 cortical neurons project to L2/3 neurons 88, 89 . We therefore investigated in L2/3 pyramidal neurons and GAD-67 + cortical interneurons the temporal profile of phasic inhibition and the influence of neurosteroid tone. In L2/3 cortical pyramidal neurons the mIPSC profile changed considerably from neonatal (P7-15), to juvenile stages (P20-24) 90 . Similar to VB neurons, the mIPSC frequency increased and their duration decreased between P7-8 and P20-24. In common with VB neurons, the mIPSC kinetic change did not result from neurosteroid insensitivity of synaptic GABA A R, but resulted from a loss of neurosteroid production as the mIPSC decay time of P7, but not of P20-24 cortical neurons was substantially reduced by pre-incubation with γ-CD, or by finasteride pre-treatment 90 . In contrast to the thalamic VB neurons, γ-CD influenced the mIPSC decay time at P10 and at P15, but as described above was inert by P20-24 (Figure 3) . Hence, the neurosteroid profile is temporally distinct from that of the thalamocortical relay neurons. Mirroring the VB neurons, incubation of the cortical slice with 5α-DHP greatly prolonged mIPSCs of P20-24 pyramidal neurons. In common with thalamic VB neurons, this effect of 5α-DHP was prevented by indomethacin and reversed by γ-CD treatment.
Collectively, these results demonstrate that when supplied with the immediate steroid precursor, the cortical slice can metabolise 5α-DHP into a GABA A Ractive neuroactive steroid 90 . Indeed, phasic inhibition in hippocampal dentate gyrus granule cells and the medium spiny neurons of the nucleus accumbens is similarly influenced by 5α-DHP (unpublished), suggesting this capacity to synthesise GABA A R-active neurosteroids may be a common feature across different brain regions. Even in the presence of γ-CD, the mIPSC decay time decreased from P7-8 to P20-24 suggesting synaptic GABA A Rs to be influenced by additional factor(s) during neonatal development. As described above, the GABA A R subunit composition may influence the mIPSC duration, with particularly the α1 subunit associated with brief events. We found the mIPSCs recorded from α1 -/-cortical L2/3 pyramidal neurons to be prolonged c.f. their wild type counterparts at all ages studied (P7-8, P10, P15 and P20-24) 90 . In common with WT neurons, treatment with γ-CD, or finasteride, reduced the mIPSC decay time of P7-15 α1 -/-neurons, but with no effect on P20-24 neurons ( Figure 3 ).
Therefore, during cortical neuron development from P7, to at least P15, the duration of phasic inhibitory events is simultaneously influenced by a neurosteroid tone and by the subunit composition of the synaptic GABA A Rs, with a waning influence of the neurosteroid occurring between P15 and P20. By contrast, for thalamocortical neurons the neurosteroid influence dissipates by P10, but the mIPSC duration continues to decrease up to P20-24 due to the exchange of synaptic α2-GABA A Rs by α1-GABA A Rs (Figure 2,3) . Finally, the frequency of mIPSCs increased during development in both cortical and thalamic neurons. However, whereas in thalamus the increased mIPSC frequency was due to a waning neurosteroid presynaptic influence, the frequency of cortical mIPSCs was not influenced by γ-CD pre-treatment 90 and therefore may reflect increased GABA-ergic innervation. Immunohistochemical and in situ hybridisation studies reveal cortical principal neurons to express both the 5α-reductase and the 3α-HSD enzymes required for allopregnanolone synthesis, whereas interneurons do not 30 . We therefore investigated whether phasic inhibition of cortical GABA-ergic interneurons is similarly influenced by neurosteroids during neonatal development.
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Recordings were made from GAD67 GFP + mice, engineered to co-express green fluorescent protein (GFP) with the GABA-synthesising γ-amino decarboxylase (GAD67) enzyme, which identifies, but does not distinguish between the three major interneuron classes in mouse cortex (i.e. somatostatin-positive (SS Recordings from GFP + neurons revealed P7-8 mIPSCs to be greatly prolonged c.f. equivalent recordings from P20-24 neurons. Intracellular γ-CD reduced the P7-8 mIPSC duration, with no effect on P20-24 neurons. Therefore, in common with cortical pyramidal neurons, interneuron phasic inhibition is influenced by neurosteroids early in postnatal development, an effect that waned by P20-24. As these interneurons do not appear to express the enzymes to synthesize allopregnanolone, these observations suggest such steroid may originate from paracrine, or endocrine sources and not emanate directly from autocrine synthesis 30 .
Neurosteroid modulation of GABA A R function during postnatal development:
Physiological relevance.
The findings presented above provide a compelling case for endogenous pregnane steroids enhancing GABA A R-mediated phasic inhibition in both cortex and thalamus during the 2 nd and 3 rd post-natal weeks. During early postnatal maturation a programmed cessation of neurosteroidogenesis and changes to the expression of synaptic GABA A R subtypes, act in concert to influence phasic inhibition. This interplay of neurosteroidogenesis with GABA A R expression follows a neuron-specific temporal pattern. In somatosensory thalamus i.e. VB neurons, the neurosteroid tone dissipates by P10, prior to the subsequent exchange of synaptic α2-GABA A Rs, by α1-GABA A Rs, which further refines phasic inhibition. By contrast, in cortical L2/3 pyramidal neurons a neurosteroid influence on phasic inhibition persists for at least another week ( Figure 3 ). The fading neurosteroid influence results from a loss of steroid substrate, or an essential co-factor, as incubation of P20-24 brain slices with 5α-DHP prolongs both cortical and thalamic mIPSCs.
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Neurosteroids enhance the function of both synaptic and extrasynaptic GABA A Rs 5,48 , thereby potentially influencing both depolarising (embryonic and early post-natal) and hyperpolarising (later post-natal) actions of GABA. The mechanism(s) that dynamically regulate neonatal neurosteroid levels are not known, although NMDA receptor activation reportedly triggers their synthesis in CA1 neurons, providing an intriguing link between neural excitation and enhancement of neural inhibition 94, 95 .
What is the physiological significance of these neonatal changes to GABA-ergic transmission? As discussed, generally GABA-ergic signals mediate a depolarizing response up to the first post-natal week (but see below). Such an effect can cause activation of specific voltage-gated conductances, e.g. Ca
2+
, which act to initiate intracellular processes crucial to neuronal migration and maturation e.g. neurite growth and synapse formation, thus permitting the subsequent establishment and synchronization of neuronal networks 2, 96, 97 . Neurosteroid levels are elevated during these early phases of neurodevelopment, i.e. during late gestation and early neonatal life, but have decreased by the third postnatal week, e.g. in the cortex 76 (See also Figure. 3 below). The neurosteroid decline coincides temporally with the switch to a hyperpolarizing GABA signal 1 . These events may be associated, as inhibition of neurosteroid synthesis, by finasteride, influences KCC2 expression in postnatal hippocampus, implying aberrant neuronal inhibition 98, 99 . Is the prolongation of the phasic GABA depolarisation by the neurosteroid action required for increased KCC2 expression? The differential neurosteroid profile of neonatal thalamic and cortical neurons (Figure 3 ), clearly warrants a comparison of the temporal expression of KCC2 in these neurons and the timing of their depolarising/hyperpolarising switch. Furthermore, certain cortical interneurons are of interest as, even for mature interneurons, GABA A R activation may cause their depolarisation 100, 101 , an action important in the emergence of brain rhythms in the fast γ-frequency domain 102-104 ( Figure 3 ).
Enhancement by neurosteroids of the GABA-evoked depolarisation may influence the temporal window of crucial processes such as neuronal migration, morphological maturation and synapse formation 3, 57 . In support, allopregnanolone promotes cell proliferation both in human and rodent brain and regulates cell-cycle and gene expression 105, 106 . Although some of these
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actions appear to be mediated by GABA A Rs, a putative involvement of Gprotein-coupled membrane progesterone receptors requires consideration 107 .
Our recordings from neonatal cortical L2/3 pyramidal and GABA-ergic interneurons reveal a role for neurosteroids in the normal maturation of the cortical network. The formation of functional GABAergic synapses on interneurons precedes the development of glutamatergic synapses in principal neurons 97, 108, 109 , although there are exceptions [110] [111] [112] . Whether neurosteroids influence the GABA A R-mediated regulation of both GABAergic and glutamatergic transmission in these distinct neuronal types remains to be determined. We have not compared in detail the temporal pattern of neurosteroid regulation of GABAergic transmission of cortical interneurons, with that now established for pyramidal neurons. Furthermore, our recordings were from GAD-67 + neurons, therefore the neurosteroid influence may differ across distinct GABAergic , SS . In particular, the overall homogenous distribution of PV + interneurons across all cortical layers except for layer 1 93, 114 appears crucial for normal development of cortical connectivity. Importantly, in schizophrenics (see below) and in animal models of this condition, there is a layer selective reduction of the cortical PV and GAD67 mRNA signal 113 .
Suggesting a putative role for neurosteroids in the development of cortical connectivity, neonatal administration of allopregnanolone at (P5), a time which precedes the functional maturation of PV + interneurons and when neurosteroids levels are relatively high (Figure 3 ), alters their distribution between superficial (II/III) and deep (V/VI) layers of the adult prefrontal cortex. Additionally, allopregnanolone reduces their abundance in the medial dorsal thalamus [115] [116] [117] . These neurosteroid effects appear to be GABA A R-mediated as they are mimicked by benzodiazepines 118 . Future genetic and pharmacological approaches to manipulate embryonic and postnatal neurosteroids may elucidate and differentiate their role in the three main classes of cortical
This article is protected by copyright. All rights reserved. . Similar studies are required across different cortical layers and areas e.g. visual vs somatosensory cortex, as translaminar GABAergic inhibition is sub-served by different interneuron classes 119 .
A similar complexity may apply to somatosensory thalamic neurons (e.g. VB and nRT), where the neurosteroid influence wanes, approximately a week prior to that of cortical pyramidal neurons (Figure 2,3) . The significance of this temporally distinct neurosteroidogenic profile is not known. However, unilateral lesion of neonatal thalamic lateral geniculate nucleus, or the VB, substantially alters the developmental expression of α1-and α5-GABA A R subunits, across the layers of the corresponding cortical territories i.e. visual, V1 and somatosensory, S1, emphasising the profound influence of thalamic inputs on the development of cortical GABAergic circuits 120 . Therefore, it is conceivable that thalamic neurosteroidogenesis may influence thalamocortical connectivity.
Neurosteroids, early life adversity and psychiatric disorders.
Given the proposed involvement of neurosteroids in brain development, experiences that perturb their levels during the establishment of neural circuitry, may subsequently influence juvenile and adult behaviour. In support, there are significant associations between abnormal levels of GABA A R-active neurosteroids e.g. allopregnanolone and a variety of neuropsychiatric disorders 33 (see below). Moreover, strategies to restore neurosteroid levels in such conditions in humans, or equivalent animal models, have proved, beneficial 33, [121] [122] [123] [124] [125] . Note the majority of psychiatric disorders, ~2/3, are diagnosed by 24 years old, or earlier, consistent with a neurodevelopmental component 126, 127 .
Environmental events, grouped under the umbrella of early-life adversity or early life stress (ELS), are now recognised as a major preventable cause of future psychiatric disorders including anxiety, depression and substance abuse [128] [129] [130] . Indeed, prior ELS may additionally be a risk factor for the future manifestation of some neurological disorders, e.g. certain forms of epilepsy 131 .
Clinically, these terms describe a variety of negative experiences early in life, ranging from poverty, malnutrition, to physical and emotional trauma, or abuse 132 .
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Patchev and colleagues (1997) first suggested that abnormal regulation of neurosteroid action as a consequence of negative experiences early in life could affect neurodevelopmental trajectories to contribute to adult psychopathology 133 . In a rodent model of maternal separation the GABA A Ractive neurosteroid (5α-THDOC), administered during early experience of reduced maternal care, prevented in adulthood, the development of a variety of neuroendocrine dysfunctions and behavioural abnormalities i.e. anxiety, associated with prior exposure to early-life adversity 133 . Whether prior ELS subsequently influences adult levels of neurosteroids and/or the dynamic regulation of their levels under a variety of physiological conditions e.g. pregnancy is not known. However, such experiences greatly influence the functional effects of GABA A R-active neurosteroids. Thus, using a naturalistic model of fragmented maternal care 134, 135 , we demonstrated that prior ELS produces a profound dysregulation of the neuronal circuits orchestrating the stress response in the paraventricular nucleus (PVN) of the hypothalamus 136 . Specifically, prior ELS greatly increased the glutamatergic excitatory drive to the CRF-releasing PVN neurons, sufficient to prevent the normal suppression of PVN firing by physiological levels of allopregnanolone 136 . Note that increased circulating allopregnanolone is purported to act as a part of a feedback circuit during acute stress, thereby limiting the duration of CRF release and consequently of glucocorticoids 21, 24 . The nucleus accumbens is part of the reward pathway and is implicated in both depression and drug abuse [137] [138] [139] . In common with thalamus and cortex, it can synthesise GABA A R-active neurosteroids (unpublished observations). Furthermore, we find that adult mice previously exposed to ELS, exhibit altered accumbal GABA A R neurotransmission and an abnormal response to cocaine, i.e. an altered locomotor sensitization, a behaviour that recapitulates in rodents aspects of drug addiction 140 . Schizophrenia is negatively influenced by early-life adversity [141] [142] [143] . The findings by Grobin and colleagues 115, 116 , discussed above, suggest a possible link between early neurosteroid dysregulation and an abnormal developmental pattern for prefrontal cortex, a region implicated in schizophrenia 113 . In support, a recent investigation revealed abnormal neurosteroid levels in a population of schizophrenic patients 144 . Furthermore, Bortolato and coworkers have implicated altered neurosteroidogenesis in the accumbal-
This article is protected by copyright. All rights reserved. mediated expression of behavioural deficits i.e. altered pre-pulse inhibition, which is typically altered in animal models of schizophrenia 145 . Thus, the impact of abnormal neurosteroid levels upon neurodevelopment may extend beyond the cortex.
In conclusion, it is now evident that endogenous neurosteroids play a vital role in fine-tuning GABA-ergic transmission during neonatal development in a neuron specific manner. GABA is crucial to establishing and developing appropriate neural connections in the developing brain. 
